Skip to content

Drug interactions

Midazolam + Repotrectinib

Severity: Moderate

Midazolam and Repotrectinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Repotrectinib induces CYP3A4 and may reduce midazolam concentrations, risking loss of sedative effect. Oral midazolam is more affected than the intravenous form.

What this interaction means in plain words

Midazolam and Repotrectinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Midazolam belongs to Central Nervous System; Repotrectinib belongs to Oncology.

Evidence level: Moderate

Why it happens

Repotrectinib induction of CYP3A4 accelerates midazolam metabolism.

What to do

Titrate midazolam to clinical effect and monitor for inadequate response, or choose a non-CYP3A4 benzodiazepine. Reassess the dose when repotrectinib is discontinued.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Midazolam and Repotrectinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Midazolam with Repotrectinib?

MediHelp rates the interaction as moderate. Midazolam and Repotrectinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Repotrectinib induces CYP3A4 and may reduce midazolam concentrations, risking loss of sedative effect. Oral midazolam is more affected than the intravenous form.

How serious is the interaction between Midazolam and Repotrectinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Titrate midazolam to clinical effect and monitor for inadequate response, or choose a non-CYP3A4 benzodiazepine. Reassess the dose when repotrectinib is discontinued.

What other medicines interact with Midazolam?

MediHelp also lists interactions of Midazolam with, for example, Atazanavir, Cobicistat, Darunavir. The full list is on the Midazolam page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in